<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846374</url>
  </required_header>
  <id_info>
    <org_study_id>21-0287</org_study_id>
    <nct_id>NCT04846374</nct_id>
  </id_info>
  <brief_title>Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis</brief_title>
  <official_title>Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To describe a novel configuration of venous access for the performance of&#xD;
      intermittent apheresis.&#xD;
&#xD;
      Participants: 20 participants at UNC who were referred for change from a vortex port to a&#xD;
      powerflow port.&#xD;
&#xD;
      Procedures (methods): Placement of one of two configurations of the powerflow port and follow&#xD;
      up visits between January 1, 2019 and December 31, 2023.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Flow Rate</measure>
    <time_frame>1 year following new port configuration placement</time_frame>
    <description>The study will compare mean change flow rate for pheresis sessions with the old system versus pheresis sessions with one of two new configurations by averaging the flow rate for up to 5 sessions using the new port configuration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Procedure Time</measure>
    <time_frame>1 year following new port configuration placement</time_frame>
    <description>The study will compare mean change in procedure time for pheresis sessions with the old system versus pheresis sessions with one of two new configurations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Use of Tissue Plasminogen Activator</measure>
    <time_frame>1 year following new port configuration placement</time_frame>
    <description>The study will compare mean change in use of tissue plasminogen activator for pheresis sessions with the old system versus pheresis sessions with one of two new configurations.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Apheresis</condition>
  <arm_group>
    <arm_group_label>PowerPort Subjects</arm_group_label>
    <description>This study will involve a chart review of patients at UNC who were referred for change from a vortex port to a powerflow port.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PowerPort</intervention_name>
    <description>The study will compare pheresis sessions with the old system versus pheresis sessions with one of two new configurations.</description>
    <arm_group_label>PowerPort Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 20 adults will be enrolled to this study. The study subjects will be recruited&#xD;
        from adults who are scheduled to receive or have received a PowerFlowâ„¢ Implantable&#xD;
        Apheresis IV Port in Vascular Interventional Radiology for their clinical care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over the age of 18 years of age.&#xD;
&#xD;
          -  Referred for change from a vortex port to a powerflow port.&#xD;
&#xD;
          -  Previously placed or scheduled placement of one of two configurations of the PowerFlow&#xD;
             port&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to read and understand English.&#xD;
&#xD;
          -  Unable to provide informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Bream, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kacee Little, MS</last_name>
    <phone>984-974-8157</phone>
    <email>kacee_little@med.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terry S Hartman, MPH,MS,CCRC</last_name>
    <phone>919-966-4997</phone>
    <email>terry_hartman@med.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kacee Little, MS</last_name>
      <phone>984-974-8157</phone>
      <email>kacee_little@med.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Terry S Hartman, MPH,MS,CCRC</last_name>
      <phone>919-966-4997</phone>
      <email>terry_hartman@med.unc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Bream, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>9 to 36 months following publication</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposes to use the data has received IRB, IEC, or REB approval, as applicable, and an executed data use/sharing agreement with UNC.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

